Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1984-3-9
|
pubmed:abstractText |
Sixty-two patients with primary carcinoma of the female urethra were treated with a combined radiation therapy (high-dose intracavitary vaginal radium and external beam). Treatment was strictly individualized, but an administered tumor dose of 5500-7000 rad (55-70 Gy) was always attempted. Forty-two patients (67.7%) had tumors of the anterior urethra, and in 20 women (32.3%) the posterior urethra was involved. In 19 patients (30.6%) the clinical diagnosis of lymph node involvement was made. The overall 5-year-survival rate was 64.5%. Patients with anterior urethral carcinoma had a higher 5-year-survival rate (71.4%) than patients with posterior carcinoma (50.0%). The favorable results underline the substantial role of radiation therapy for this malignancy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0090-8258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
58-63
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6420243-Adult,
pubmed-meshheading:6420243-Aged,
pubmed-meshheading:6420243-Brachytherapy,
pubmed-meshheading:6420243-Carcinoma,
pubmed-meshheading:6420243-Female,
pubmed-meshheading:6420243-Humans,
pubmed-meshheading:6420243-Lymphatic Metastasis,
pubmed-meshheading:6420243-Middle Aged,
pubmed-meshheading:6420243-Radiotherapy, High-Energy,
pubmed-meshheading:6420243-Radiotherapy Dosage,
pubmed-meshheading:6420243-Radium,
pubmed-meshheading:6420243-Urethral Neoplasms
|
pubmed:year |
1984
|
pubmed:articleTitle |
Radiation therapy for primary carcinoma of the female urethra: a survey over 25 years.
|
pubmed:publicationType |
Journal Article
|